Literature DB >> 11929356

Anabolic steroids: a review for the clinician.

Eric C Kutscher1, Brian C Lund, Paul J Perry.   

Abstract

The number of athletes self-administering ergogenic pharmacological agents to increase their competitive edge continues to be a problem. Most athletes using anabolic steroids (AS) have acquired a crude pharmacological database regarding these drugs. Their opinions regarding steroids have been derived from their subjective experiences and anecdotal information. For this reason, traditional warnings regarding the lack of efficacy and potential dangers of steroid misuse are disregarded. A common widely held opinion among bodybuilders is that the anabolic steroid experts are the athletic gurus who for years have utilised themselves as the experimental participants and then dispensed their empirical findings. This review will address the common anabolic steroid misconceptions held by many of today's athletes by providing an evaluation of the scientific literature related to AS in athletic performance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929356     DOI: 10.2165/00007256-200232050-00001

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  49 in total

1.  Adaptation of human skeletal muscle to training and anabolic steroids.

Authors:  F Kadi
Journal:  Acta Physiol Scand Suppl       Date:  2000-01

2.  Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.

Authors:  A M Matsumoto
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

3.  Anabolic steroid-induced hypogonadotropic hypogonadism.

Authors:  J P Jarow; L I Lipshultz
Journal:  Am J Sports Med       Date:  1990 Jul-Aug       Impact factor: 6.202

4.  Androgenic anabolic steroids and arterial structure and function in male bodybuilders.

Authors:  M A Sader; K A Griffiths; R J McCredie; D J Handelsman; D S Celermajer
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

5.  Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial.

Authors:  S N Seidman; E Spatz; C Rizzo; S P Roose
Journal:  J Clin Psychiatry       Date:  2001-06       Impact factor: 4.384

Review 6.  Androgens in men--uses and abuses.

Authors:  C J Bagatell; W J Bremner
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245

7.  Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial.

Authors:  H G Pope; E M Kouri; J I Hudson
Journal:  Arch Gen Psychiatry       Date:  2000-02

Review 8.  The cardiac toxicity of anabolic steroids.

Authors:  M L Sullivan; C M Martinez; P Gennis; E J Gallagher
Journal:  Prog Cardiovasc Dis       Date:  1998 Jul-Aug       Impact factor: 8.194

Review 9.  Anabolic-androgenic steroids. Current issues.

Authors:  C E Yesalis; M S Bahrke
Journal:  Sports Med       Date:  1995-05       Impact factor: 11.136

Review 10.  Atherogenic effects of anabolic steroids on serum lipid levels. A literature review.

Authors:  G Glazer
Journal:  Arch Intern Med       Date:  1991-10
View more
  28 in total

1.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

Review 2.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

3.  Doping in sports and its spread to at-risk populations: an international review.

Authors:  David A Baron; David M Martin; Samir Abol Magd
Journal:  World Psychiatry       Date:  2007-06       Impact factor: 49.548

4.  Short QT interval: A novel predictor of androgen abuse in strength trained athletes.

Authors:  Mohammad Ali Babaee Bigi; Amir Aslani; Arsalan Aslani
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

Review 5.  Popular sports supplements and ergogenic aids.

Authors:  Mark Juhn
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 6.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

7.  The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates.

Authors:  Harrison G Pope; Gen Kanayama; Alison Athey; Erin Ryan; James I Hudson; Aaron Baggish
Journal:  Am J Addict       Date:  2013-09-20

Review 8.  Anabolic steroid abuse and dependence.

Authors:  Kirk J Brower
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

Review 9.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

10.  Rhabdomyolysis of the deltoid muscle in a bodybuilder using anabolic-androgenic steroids: a case report.

Authors:  Uri Farkash; Nogah Shabshin; Moshe Pritsch Perry
Journal:  J Athl Train       Date:  2009 Jan-Feb       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.